Eli Lilly and Co (TSX:LLY) Total Noninterest Expense

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSX:LLY Eli Lilly and Co TSX:LLY
76 GF Score
Price C$42.51
GF Value C$52.25
Valuation Modestly Undervalued
! 6 Warning Signs
View Full Analysis

What is Eli Lilly and Co Total Noninterest Expense?

Total Noninterest Expense only applies to banks.

TSX:LLY
76GF Score
Eli Lilly and Co TSX:LLY
Total Noninterest Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Eli Lilly and Co (TSX:LLY) Overvalued in 2026?

Based on GuruFocus' analysis, Eli Lilly and Co stock appears to be undervalued. The current stock price of C$42.51 is trading 18.6% below its estimated GF Value™ of C$52.25. GuruFocus considers Eli Lilly and Co to be Modestly Undervalued.

Key valuation signals for TSX:LLY:

  • Total Noninterest Expense:
  • GF Value™: C$52.25 vs. price of C$42.51 (18.6% below fair value)
  • GF Score™: 76/100 with 6 warning signs

No single metric tells the full story. See the TSX:LLY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Eli Lilly and Co Business Description

Address Lilly Corporate Center, Indianapolis, IN, USA, 46285
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio and Jaypirca for cancer; Mounjaro, Zepbound, Foundayo, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
76GF Score

Get the complete analysis for TSX:LLY

Total Noninterest Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

C$42.51
Price
C$52.25
GF Value